MNKD News Alert Mannkind Corp (MNKD) 5.11 12/13/2014 04:36:0

New Post Public Reply Private Reply Replies (0) Message Board

Dec 13, 2014 at 5:36 AM

Mannkind Corp (MNKD) 5.11 $MNKD

Is MannKind Corporation in Bed With Crooks? And Should Investors Care?
Brian Orelli, The Motley Fool - Motley Fool - Fri Dec 12, 6:45AM CST
MannKind 's marketing partner Sanofi might be in big trouble. In a lawsuit filed last week, a former Sanofi employee claims she was fired after resisting the approval of nine contracts with consulting firms worth $34 million, because she...
SFY: 3.08 (-0.09), MNKD: 5.11 (-0.14)

Critical Alerts For MannKind, Merck, Alnylam Pharmaceuticals, Nu Skin Enterprises and Organovo Released By InvestorsObserver
PR Newswire - Tue Dec 09, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for MNKD, MRK, ALNY, NUS and ONVO.
ALNY: 100.45 (+0.23), ONVO: 6.35 (+0.85), NUS: 40.16 (-2.78), MRK: 57.72 (-1.62), MNKD: 5.11 (-0.14)

Mannkind Reality Check Redux: 82.4 Million Reasons To Leave Your Lover!
Looking For Diogenes - at Seeking Alpha - Tue Dec 09, 1:36AM CST

MNKD: 5.11 (-0.14)

Biotech Weekly: Everything You Want To Know About Small Cap Biotech Cult Stocks
Daniel Ward - at Seeking Alpha - Mon Dec 08, 10:35AM CST

HEB: 0.25 (-0.01), IBIO: 0.69 (unch), MNKD: 5.11 (-0.14), ARNA: 3.91 (-0.18)

Brinson Patrick's Christopher S. James: All Catalysts Are Not Created Equal
Life Sciences Report - Seeking Alpha - Fri Dec 05, 7:55AM CST
Why do some good-news milestones cause stocks to languish, or even fall? Neurosurgeon Christopher James, managing director and senior biotechnology analyst at Brinson Patrick Securities, performs due diligence on stocks, in part, by connecting his...
BCRX: 10.06 (+0.02), STEM: 1.02 (-0.01), RTRX: 10.12 (+0.24), RGLS: 16.06 (-0.25), SNY: 45.16 (-1.05), MNKD: 5.11 (-0.14)

Losing Confidence In MannKind
Orange Peel Investments - at Seeking Alpha - Fri Dec 05, 7:13AM CST

MNKD: 5.11 (-0.14)

MannKind: Strategy, Accounting, And Technosphere At Piper Jaffray Healthcare Conference
Psycho Analyst - at Seeking Alpha - Thu Dec 04, 7:36AM CST

MNKD: 5.11 (-0.14), SNY: 45.16 (-1.05)

MannKind: The Newest Bear Talking Point Is Absurd
The Kumquat - at Seeking Alpha - Fri Nov 28, 7:22AM CST

MNKD: 5.11 (-0.14), SNY: 45.16 (-1.05)

Will Insulin Pricing Be MannKind Corporation's Downfall?
Brian Orelli, The Motley Fool - Motley Fool - Wed Nov 26, 7:15AM CST
The biggest worry for MannKind has been whether doctors would prescribe its inhaled insulin drug, Afrezza, which would take market share away from injected insulin currently prescribed by physicians . But there might be a bigger concern: whether...
NVO: 44.48 (-1.14), LLY: 69.55 (-2.06), SNY: 45.16 (-1.05), MNKD: 5.11 (-0.14)

MannKind Corporation to Present at The 26th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Tue Nov 25, 4:00PM CST
MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that it will present at The 26 Annual Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014 at 3:00 PM (ET) at the New York Palace Hotel in New York City.
MNKD: 5.11 (-0.14)

Puma Is As Expensive As MannKind Is Cheap
George Rho - at Seeking Alpha - Tue Nov 25, 1:43PM CST

MNKD: 5.11 (-0.14), PBYI: 196.34 (-7.66)

Should MannKind's Shareholders Buy Al Mann's New Company?
Motley Fool Staff - Motley Fool - Tue Nov 25, 7:03AM CST
Source: Al Mann Foundation Al Mann is on the short list of medical visionaries that have proven themselves with commercial success in the past, but Mann's self-named MannKind has been anything but a smooth ride for investors over the past few...
MDT: 72.52 (-1.25), SNY: 45.16 (-1.05), MNKD: 5.11 (-0.14)

MannKind: Does Size Matter?
Looking For Diogenes - at Seeking Alpha - Mon Nov 24, 10:12AM CST

MNKD: 5.11 (-0.14)

Sanofi's New Medicines Seminar: Implications For Afrezza
Psycho Analyst - at Seeking Alpha - Fri Nov 21, 3:59PM CST

MNKD: 5.11 (-0.14), SNY: 45.16 (-1.05)

I'm Not Talking About GoPro Or Ebola-Related Names (Although I Could Probably Talk About GoPro...)
Interactive Brokers - at Seeking Alpha - Fri Nov 21, 5:37AM CST
China Green Agriculture Inc. (NYSE: CGA ) and Whiting USA Trust I (NYSE: WHX ) continue to be two of the hardest to borrow names. WHX's latest dividend has reduced available supply and skewed current borrow rates (record date is Nov. 19)....
GPRO: 60.52 (+0.47), CGA: 1.40 (-0.28), PLUG: 2.93 (-0.17), JMEI: 13.50 (-0.01), AFSI: 56.87 (-0.58), WHX: 1.95 (-0.13), RWLK: 21.22 (-0.28), LAKE: 10.79 (-0.40), LOCO: 22.88 (+0.60), TRUE: 21.35 (-1.68), MNKD: 5.11 (-0.14), MBLY: 40.78 (-1.19), RGR: 34.50 (-0.45), CMGE: 19.63 (+0.14), ANFI: 12.00 (-0.16)

Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind
at The Street - Fri Nov 21, 5:00AM CST
Biotech columnist Adam Feuerstein answers readers' questions about health care.
NWBO: 4.98 (+0.04), CLDX: 18.03 (-0.16), MNKD: 5.11 (-0.14), PBYI: 196.34 (-7.66)

Second Sight off to a strong start
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 7:53AM CST

EYES: 15.24 (+0.71), MNKD: 5.11 (-0.14)

Sanofi: Recent Plunge Is A Buying Opportunity
Nicholas Kitonyi - at Seeking Alpha - Tue Nov 18, 8:00AM CST

NVO: 44.48 (-1.14), PFE: 30.95 (-0.70), MRK: 57.72 (-1.62), LLY: 69.55 (-2.06), SNY: 45.16 (-1.05), MNKD: 5.11 (-0.14)

Post Earnings Update: MannKind Has Climbed 4.1% Higher in Past 2 Weeks (MNKD)
Comtex SmarTrend(R) - Mon Nov 17, 2:59PM CST
Two weeks ago on November 3rd, 2014 MannKind (NASDAQ:MNKD) reported earnings and analysts, on average, expected a loss of $0.02 on sales of $41.0 million. The company actually reported a loss of $0.09 per share on sales of $0.0 thousand, missing EPS estimates by $0.07 and missing revenue estimates by $41.0 million. Since the company's report, shares of MannKind have risen from $5.92 to $6.16, representing a gain of 4.1% in the past 14 days.
MNKD: 5.11 (-0.14)

Critical Alerts For MannKind, CyberArk Software, Best Buy, Nordstrom and ExOne Released By InvestorsObserver
PR Newswire - Fri Nov 14, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for MNKD, CYBR, BBY, JWN and XONE.
CYBR: 37.98 (+0.13), XONE: 17.94 (-0.33), JWN: 74.65 (+0.46), BBY: 36.85 (+0.22), MNKD: 5.11 (-0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Health Net Invests $3 Million in Stockton Housing

Putting a Roof Over Stockton's Head The talk of the town in Stockton is Health Net stepping up with a $3 million investment. This isn't just dropping loose change in a jar; it's about tackling a mammoth issue—making affordable housing more than just a pipe dream for 75 families. Community-driven, they say. What a cozy way to paint a picture of bridging that brutal gap...

Partner Joins Yardi ICN, Boosting Data Quality for Clients

Strategic Alliances in Real Estate Data When Partner Engineering and Science, Inc. says they're hooking up with the Yardi Independent Consultant Network (ICN), that's not just some boardroom handshake. It's a play that could shake up data services in the real estate game. Look, there's plenty of chatter about digitizing property management, but without killer data, those...

Dyania, NVIDIA Team Up: AI Transforming Patient Care

Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...

D-Wave's 9.5% Drop: Fraud Lawsuit Raises Investor Ire

Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...

Euroandinos Paita Closes Consent for 2037 Notes

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

PenFed Fuels Aggie Spirit with Blackout Game Activation

A Different Kind of Game Day Experience Ah, there's nothing quite like the vibrancy of a Texas A&M game day, especially when it's a blackout event. On November 14, fans aren't just getting the good old college football thrills; they're diving headfirst into an extravaganza, courtesy of PenFed Credit Union. You might know them as the go-to credit union for military folks,...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Fly-E Faces Revenue Drop Amid Retail Restructuring

Downturn Despite Strategic Restructuring Today, we're diving into Fly-E Group, Inc. (NASDAQ:FLYE) and the latest shakeup in their financials—spoiler alert, it's riding a downward slope. Quarter two of fiscal 2027 didn't exactly shine a light on profitability. Net revenues slid, dropping to $2.6 million this quarter, down from $3.9 million the previous year. Tack that up...

LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

FiEE Rockets to Profitability with 382% Revenue Surge

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...